Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 18;14(2):211.
doi: 10.3390/diagnostics14020211.

Quantitative Analysis of Retinal Perfusion in Patients with Frontotemporal Dementia Using Optical Coherence Tomography Angiography

Affiliations

Quantitative Analysis of Retinal Perfusion in Patients with Frontotemporal Dementia Using Optical Coherence Tomography Angiography

Eliane Luisa Esser et al. Diagnostics (Basel). .

Abstract

Background: Optical coherence tomography angiography (OCT-A) provides detailed visualization of the perfusion of the vascular network of the eye. While in other forms of dementia, such as Alzheimer's disease and mild cognitive impairment, reduced retinal perfusion was frequently reported, data of patients with frontotemporal dementia (FTD) are lacking.

Objective: Retinal and optic nerve head perfusion was evaluated in patients with FTD with OCT-A. Quantitative OCT-A metrics were analyzed and correlated with clinical markers and vascular cerebral lesions in FTD patients.

Methods: OCT-A was performed in 18 eyes of 18 patients with FTD and 18 eyes of 18 healthy participants using RTVue XR Avanti with AngioVue. In addition, patients underwent a detailed ophthalmological, neurological, and neuropsychological examination, cerebral magnetic resonance imaging (MRI), and lumbar puncture.

Results: The flow density in the optic nerve head (ONH) and in the superficial capillary plexus (SCP) of the macula of patients was significantly lower compared to that of healthy controls (p < 0.001). Similarly, the VD in the deep capillary plexus (DCP) of the macula of patients was significantly lower compared to that of healthy controls (p < 0.001). There was no significant correlation between the flow density data, white matter lesions in brain MRI, cognitive deficits, and cerebrospinal fluid markers of dementia.

Conclusions: Patients with FTD showed a reduced flow density in the ONH, and in the superficial and deep retinal capillary plexus of the macula, when compared with that of healthy controls. Quantitative analyses of retinal perfusion using OCT-A may therefore help in the diagnosis and monitoring of FTD. Larger and longitudinal studies are necessary to evaluate if OCT-A is a suitable biomarker for patients with FTD.

Keywords: flow density; frontotemporal dementia; optical coherence tomography angiography; retinal and optic nerve head perfusion.

PubMed Disclaimer

Conflict of interest statement

All authors report no conflicts of interest relevant to this study. The full list of commercial interests for each author is listed below. Julia Krämer received honoraria for lecturing from Biogen, Novartis, Sanofi Genzyme, Roche, Mylan and Teva, and financial research support from Sanofi Genzyme, Novartis, Roche, and Amicus Therapeutics.

Figures

Figure 1
Figure 1
The macula (A) and color-coded vascular density maps (B) from superficial retinal OCT angiograms in a frontotemporal dementia (FTD) patient and a healthy control. Three different flow densities were analyzed: the parafoveal flow density (diameter from 1 mm to 2.5 mm), the whole en face flow density (average flow density of the complete 2.5 mm circle), and the foveal flow density (small white circle with a diameter of 1 mm).
Figure 2
Figure 2
Comparison of the flow density (%) obtained in the superficial and deep capillary plexus of the macula and optic disc OCT angiogram in patients with FTD and healthy controls (p < 0.001). **** = statistically highly significant.

Similar articles

Cited by

References

    1. Bang J., Spina S., Miller B.L. Frontotemporal dementia. Lancet. 2015;386:1672–1682. doi: 10.1016/S0140-6736(15)00461-4. - DOI - PMC - PubMed
    1. Boeve B.F., Boxer A.L., Kumfor F., Pijnenburg Y., Rohrer J.D. Advances and controversies in frontotemporal dementia: Diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 2022;21:258–272. doi: 10.1016/S1474-4422(21)00341-0. - DOI - PubMed
    1. Ferrari L., Huang S.-C., Magnani G., Ambrosi A., Comi G., Leocani L. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer’s Disease. J. Alzheimer’s Dis. 2017;56:1101–1107. doi: 10.3233/JAD-160886. - DOI - PubMed
    1. Krämer J., Lueg G., Schiffler P., Vrachimis A., Weckesser M., Wenning C., Pawlowski M., Johnen A., Teuber A., Wersching H., et al. Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia. J. Alzheimer’s Dis. 2018;63:239–253. doi: 10.3233/JAD-170224. - DOI - PubMed
    1. Moinuddin O., Khandwala N.S., Young K.Z., Sathrasala S.K., Barmada S.J., Albin R.L., Besirli C.G. Role of Optical Coherence Tomography in Identifying Retinal Biomarkers in Frontotemporal Dementia: A Review. Neurol. Clin. Pract. 2021;11:e516–e523. doi: 10.1212/CPJ.0000000000001041. - DOI - PMC - PubMed

LinkOut - more resources